雜志介紹

Drug Resistance Updates雜志介紹

《Drug Resistance Updates》是一本以English為主的未開放獲取國際優秀期刊，中文名稱耐藥性更新，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為15.8，最新CiteScore 指數為26.2。

本刊近期中國學者發表的論文主要有：

• CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis

  Author: Wu, Jing; Zhou, Zhijun; Li, Jin; Liu, Huifang; Zhang, Huaqi; Zhang, Junchang; Huang, Weibin; He, Yulong; Zhu, Shiyu; Huo, Mingyu; Liu, Mingyang; Zhang, Changhua

• Overcoming cancer chemotherapy resistance by the induction of ferroptosis

  Author: Wang, Yumin; Wu, Xiaorui; Ren, Zhao; Li, Yulin; Zou, Wailong; Chen, Jichao; Wang, Hongquan

• Single-cell transcriptional profiling uncovers the association between EOMES+CD8+T cells and acquired EGFR-TKI resistance

  Author: Wang, Guosheng; Sun, Jiaxing; Zhang, Jing; Zhu, Qiping; Lu, Jingjing; Gao, Shaoyong; Wang, Feilong; Yin, Qi; Wan, Yuan; Li, Qiang

• Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat

  Author: Upadhayay, Aditya; Ling, Jingjing; Pal, Dharm; Xie, Yuhao; Ping, Feng-Feng; Kumar, Awanish

英文介紹

Drug Resistance Updates雜志英文介紹

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.

It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.

Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.

*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease

*Describes emerging technologies and therapies, particularly those that overcome drug resistance

*Emphasises common themes in microbial and cancer research